| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 07/01/2004 | WO2004054594A1 Cell death inhibitor |
| 07/01/2004 | WO2004054593A1 Ophthalmic compositions containing bile products from animal |
| 07/01/2004 | WO2004054592A1 Herbal preparation for management of cardiovascular and neurologic disorders |
| 07/01/2004 | WO2004054433A2 Forming iron nitrosyl hemoglobin |
| 07/01/2004 | WO2004034984A3 Cell-seeded tissue-engineered polymers for treatment of intracranial aneurysms |
| 07/01/2004 | WO2004031371A3 Programmable scaffold and methods for making and using the same |
| 07/01/2004 | WO2004020014A3 Method of controlling pharmacokinetics of immunomodulatory compounds |
| 07/01/2004 | WO2004019865A3 Amelioration of effects of cigarette smoke |
| 07/01/2004 | WO2003080798A3 Muscle cells and their use in cardiac repair |
| 07/01/2004 | WO2003080649A3 Induction of hepatocyte proliferation in vitro by inhibition of cell cycle inhibitors |
| 07/01/2004 | WO2002062834A3 Mixture of peptides originating from a nef protein and applications thereof |
| 07/01/2004 | US20040127696 Growth differentiation factor-7 |
| 07/01/2004 | US20040127686 Signal transduction regulator binding protein for identifying modulators for prevention and treatment of cardiomyopic hypertrophy, heart failure and diabetes; drug screening |
| 07/01/2004 | US20040127437 Combined therapeutical treatment of hyperproliferative diseases |
| 07/01/2004 | US20040127410 Circular permuteins of flt3 ligand |
| 07/01/2004 | US20040127406 acinar cells undergo a 3-4 fold expansion together with transdifferentiation into a modified cell phenotype (IP cells) showing characteristics of acinar cells and liver cells and are further transformed to insulin-producing cells |
| 07/01/2004 | US20040126885 Delivery vehicle for recombinant proteins |
| 07/01/2004 | US20040126881 Fibrinogen and thrombin protein matrix for culturing tissues for use in skin grafts and replacement; tissue engineering |
| 07/01/2004 | US20040126880 Using gamma radiation to inactivate, decrease and/or remove contaminants associated with functioning biological materials, biochemical entities and biologically active molecules and storing materials at room temperature |
| 07/01/2004 | US20040126878 Method for the preparation of immunologically inert amniotic membranes |
| 07/01/2004 | US20040126870 Ncc2705-the genome of a bifodobacterium |
| 07/01/2004 | US20040126869 Method of producing infectious reovirus |
| 07/01/2004 | US20040126862 Comprises nucleotide sequences coding protein of urogenital system for identifying moduators for treatment of cell proliferative and metastatic disorders |
| 07/01/2004 | US20040126823 Identifying oncogenic kinase modulators which ca n be used in the prevention and treatment inflammation an d cell proliferative disorders |
| 07/01/2004 | US20040126799 First nucleotide sequence comprises adenine residue at position 1033 or equivalent; reducing disease treatment side effects |
| 07/01/2004 | US20040126758 homologous to the known fibrinogen derived haptotactic peptides; shown to elicit activity from fibroblasts, endothelial and smooth muscle cells; for wound healing and enhancing osteogenesis/angiogenesis in vivo with/without medical implant |
| 07/01/2004 | US20040126751 Method of prolonging the life-span of living cells using NADH, NADPH and ADP-ribose |
| 07/01/2004 | US20040126432 Blood flow enhancer and inflamation reducer, anticholesterol agents and oxidation reduction |
| 07/01/2004 | US20040126382 Two-step immunization procedure against chlamydia infection |
| 07/01/2004 | US20040126380 Administering a neurotoxin ; therapy for enlargement of prostate gland |
| 07/01/2004 | US20040126364 Antiinflammatory agents; genetic engineered interleukins; oral diseases |
| 07/01/2004 | US20040126363 Cd19-specific redirected immune cells |
| 07/01/2004 | US20040126356 Compositions and methods for diagnosis and treatment of cardiovascular disorders |
| 07/01/2004 | US20040124157 Apparatus for the continuous separation of biological fluids into components and method of using same |
| 07/01/2004 | CA2840513A1 Recombinant proteins of parapoxvirus ovis and pharmaceutical compositions therefrom |
| 07/01/2004 | CA2510227A1 A method of treating a malignancy in a subject via direct picornaviral-mediated oncolysis |
| 07/01/2004 | CA2509817A1 Forming iron nitrosyl hemoglobin |
| 06/30/2004 | EP1433855A2 Plasmids suitable for il-2 expression |
| 06/30/2004 | EP1433525A1 Sensitive substance encapsulation |
| 06/30/2004 | EP1433487A1 Method of bone regeneration |
| 06/30/2004 | EP1433483A1 Reovirus for the treatment of neoplasia wherein double stranded RNA-activated protein kinase (PKR) is inactivated or deleted |
| 06/30/2004 | EP1432991A1 Identification and isolation of somatic stem cells and uses thereof |
| 06/30/2004 | EP1432791A1 Alphavirus replicon vector systems |
| 06/30/2004 | EP1432738A1 Carbohydrate binding domain containing fusion proteins for delivery of therapeutic and other agents, and compositions containing them |
| 06/30/2004 | EP1432732A2 Pharmaceutical composition for diagnosis, prevention or treatment of a tumorous state, comprising a modulator of the actin polymerisation state |
| 06/30/2004 | EP1432729A2 Peyers's patch and/or m-cell targeting ligands |
| 06/30/2004 | EP1432435A1 Enamel matrix protein compositions for modulating immune response |
| 06/30/2004 | EP1432426A2 USE OF UNMETHYLATED CpG |
| 06/30/2004 | EP1169063B1 Treatment of intracellular infection |
| 06/30/2004 | EP1032418B1 Compact epstein-barr virus replicons |
| 06/30/2004 | EP0765385B1 COMPOSITIONS AND METHOD OF STIMULATING THE PROLIFERATION AND DIFFERENTIATION OF HUMAN FETAL AND ADULT PANCREATIC CELLS $i(EX VIVO) |
| 06/30/2004 | EP0690722B1 Composition and method for reducing toxicity of biologically-active factors |
| 06/30/2004 | CN1509337A New polynucleotides and polypeptides of IFN alpha-17 gene |
| 06/30/2004 | CN1509327A CD4+CD25+regulatory T cells from human blood |
| 06/30/2004 | CN1509182A Use of extracts and preparations from iris plants and tectorigenin as organ selective medicament for treating urethra disease |
| 06/30/2004 | CN1509144A Prebiotic and probiotic compositions and method for use in gut-based therapies |
| 06/30/2004 | CN1507924A Preparation method for producing fibrin gel and platelect gel using human thromblase |
| 06/30/2004 | CN1507913A Medicinal composition for treating wound surface |
| 06/30/2004 | CN1507877A Phenergan bile tablet |
| 06/30/2004 | CN1155708C DNA of encoding plasminogen excited protein |
| 06/30/2004 | CN1155706C Method for treating amyotrophic lateral sclerosis |
| 06/30/2004 | CN1155406C Nitrogen oxide generation inhibitor |
| 06/30/2004 | CN1155397C External-use analgesic and its prepn |
| 06/30/2004 | CN1155396C Medicine for guiding cancer cell differentiation and its use on treating and preventing cancer |
| 06/30/2004 | CN1155395C Process for preparing roaster colostrum from pig's antibody serum |
| 06/29/2004 | US6756523 Adenovirus vectors for the transfer of foreign genes into cells of the central nervous system particularly in brain |
| 06/29/2004 | US6756477 Comprise breast tumor proteins, immunogenic portions thereof, or polynucleotides that encode such portions |
| 06/29/2004 | US6756211 Neutropohil inhibitors |
| 06/29/2004 | US6756065 Anti-oxidant preparation based on plant extracts for the treatment of circulation and adiposity problems |
| 06/29/2004 | US6756042 Salmonella vaccine; immunogenicity; reduced possibility of strain revertion to reactive form; safe; limited side effects |
| 06/29/2004 | US6755856 Methods and apparatus for stenting comprising enhanced embolic protection, coupled with improved protection against restenosis and thrombus formation |
| 06/29/2004 | CA2031518C Endothelial cell-leukocyte adhesion molecules (elams) and molecules involved in leukocyte adhesion (milas) |
| 06/24/2004 | WO2004053101A2 Methods and compositions using compounds from fetal cells and tissues to improve condition of skin |
| 06/24/2004 | WO2004053096A2 Engineering three-dimensional tissue structures using differentiating embryonic stem cells |
| 06/24/2004 | WO2004052462A1 Composition comprising lactobacilli or bifidobacteria and use thereof |
| 06/24/2004 | WO2004052380A1 Cholesterol-lowering preparation, food supplement and foodstuff, and methods for preparing same |
| 06/24/2004 | WO2004052379A1 Antidiarrheal composition |
| 06/24/2004 | WO2004052276A2 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 06/24/2004 | WO2004052273A2 Pharmaceutical compositions preparation of peptides, secreted by the snake venom glands |
| 06/24/2004 | WO2004052177A2 Cell-based therapies for ischemia |
| 06/24/2004 | WO2004030706A3 Bioactive implants |
| 06/24/2004 | WO2004022716A3 Recombinatant mutants of rhabdovirus and methods of use thereof |
| 06/24/2004 | WO2003101389B1 Relief of aids symptoms |
| 06/24/2004 | WO2003068800A3 Isolated peptides which bind to hla molecules and uses thereof |
| 06/24/2004 | WO2003047589A8 Pharmaceutical compositions containing 3,4-propinoperhydropurines and uses thereof for blocking neuronal transmission |
| 06/24/2004 | US20040121976 Anti-inflammatory vectors |
| 06/24/2004 | US20040121972 Methylenetetrahydrofolate reductase inhibitors and uses thereof |
| 06/24/2004 | US20040121963 Composition for inhibiting hiv activity extracted from paecilomyces sp. (tochu-kaso) j300 |
| 06/24/2004 | US20040121466 Alphavirus RNA replicon systems |
| 06/24/2004 | US20040121461 Bone marrow or cord blood cells transplanted into rat animal model comprised of demyelinated axons in order to remyelinate defective nervous system tissues; gene therapy and neurodegenerative disorders |
| 06/24/2004 | US20040121460 Pancreatic tissue culture prepared from embryonic stem cells for treatment of panreactic and diabetic disorders |
| 06/24/2004 | US20040121443 Modified protamine with reduced immunogenicity |
| 06/24/2004 | US20040121302 for photo-processing of blood products, pharmaceuticals, injectables and vaccines using non-laser light source(s); for inactivating pathogens |
| 06/24/2004 | US20040121301 Agent imparting resistance to external stimuli |
| 06/24/2004 | US20040121300 includes a hydroxyethyl starch and/or derivative thereof alone or in combination with either dimethyl sulfoxide (DMSO) or glycerol; for recombinant live cancer cellular vaccine; kits |
| 06/24/2004 | US20040121020 Composition |
| 06/24/2004 | US20040120987 Process and composition for controlling fecal hair excretion and trichobezoar formation |
| 06/24/2004 | US20040120963 bacteria belongs to the genus Megasphaera or Mitsuokella |
| 06/24/2004 | US20040120952 Anti-TNF antibodies and peptides of human tumor necrosis factor |
| 06/24/2004 | US20040120944 efficacy of the antibody is increased by taking all lots of eggs produced by an avian over at least the first 30 weeks following immunization, wherein all lots of eggs contain antibodies produced in response to the immunization, and blending |